Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Phospho-Axl (Tyr779) Mouse anti-Human, Clone: 713610, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer:  Invitrogen MA524334

Catalog No. PIMA524334


Add to cart

Description

Description

Reconstitute in sterile PBS to a final concentration of 0.5 mg/mL.

The protein encoded by this gene is a member of the receptor tyrosine kinase subfamily. Although it is similar to other receptor tyrosine kinases, this protein represents a unique structure of the extracellular region that juxtaposes IgL and FNIII repeats. It transduces signals from the extracellular matrix into the cytoplasm by binding growth factors like vitamin K-dependent protein growth-arrest-specific gene 6. It is involved in the stimulation of cell proliferation and can also mediate cell aggregation by homophilic binding. Alternatively spliced transcript variants encoding different isoforms have been identified.
Specifications

Specifications

Phospho-Axl (Tyr779)
Monoclonal
0.5 mg/mL
PBS with 5% trehalose and No Preservative
P30530
JTK11, UFO, AXL oncogene, AXL transforming sequence, oncogene AXL, tyrosine-protein kinase receptor UFO
Mouse
IgG1
100 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
558
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Western Blot
713610
Unconjugated
AXL
Lyophilized
AXL
Phosphopeptide containing the human AxlY779 site
Protein A/G
RUO
Antibody
Monoclonal
Human
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit